This guide explains what BPC-157 is, who it may help, how it works, the benefits and the real limits of the evidence, how it is delivered, and what treatment involves
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
Limited value of pro-inflammatory oxylipins and cytokines as circulating biomarkers in endometriosis - a targeted omics study
Combined with semaglutide (CagriSema), it demonstrated 20.4% weight loss in the Phase 3 REDEFINE 1 trial, approaching the efficacy of bariatric surgery
Once a patient is on a maintenance dose, their B12 levels are generally stable, and a single days difference is unlikely to have a clinical impact
Realistic expectations: Significantly faster corneal wound healing (30-40% based on RGN-259 trials)